{"id":20777,"date":"2023-03-02T20:13:05","date_gmt":"2023-03-02T20:13:05","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/press-releases\/ipsen-finalise-lacquisition-dalbireo-et-etend-son-portefeuille-en-maladies-rares\/"},"modified":"2024-07-29T08:38:34","modified_gmt":"2024-07-29T06:38:34","slug":"ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio\/","title":{"rendered":"Ipsen finalise l\u2019acquisition d\u2019Albireo et \u00e9tend son portefeuille en Maladies Rares"},"content":{"rendered":"\n